To further appreciate the significance of PAR4 in stimulating stem cell marker expression levels, HT-29 colon cancer cells were subjected to AYPGKF for PAR4 activation and either treated or not with tcY-NH2, a potent antagonist of PAR4. Here, F2RL3 is linked to malignant colon neoplasm.